$3.05
3.48% day before yesterday
Nasdaq, May 30, 10:03 pm CET
ISIN
US09061H3075
Symbol
BMRA

Biomerica, Inc. Stock price

$3.05
-0.57 15.75% 1M
-0.24 7.42% 6M
+0.65 27.04% YTD
-1.99 39.48% 1Y
-23.67 88.59% 3Y
-47.75 94.00% 5Y
-4.47 59.44% 10Y
Nasdaq, Closing price Fri, May 30 2025
-0.11 3.48%
ISIN
US09061H3075
Symbol
BMRA
Sector

Key metrics

Market capitalization $7.76m
Enterprise Value $4.70m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.83
P/S ratio (TTM) P/S ratio 1.37
P/B ratio (TTM) P/B ratio 1.40
Revenue growth (TTM) Revenue growth 5.19%
Revenue (TTM) Revenue $5.68m
EBIT (operating result TTM) EBIT $-5.10m
Free Cash Flow (TTM) Free Cash Flow $-4.29m
Cash position $3.06m
EPS (TTM) EPS $-2.02
Short interest 1.58%
Show more

Is Biomerica, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Biomerica, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Biomerica, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Biomerica, Inc.:

Buy
100%

Financial data from Biomerica, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Feb '25
+/-
%
5.68 5.68
5% 5%
100%
- Direct Costs 4.91 4.91
3% 3%
86%
0.77 0.77
24% 24%
14%
- Selling and Administrative Expenses 4.83 4.83
15% 15%
85%
- Research and Development Expense 1.04 1.04
35% 35%
18%
-4.49 -4.49
32% 32%
-79%
- Depreciation and Amortization 0.61 0.61
771% 771%
11%
EBIT (Operating Income) EBIT -5.10 -5.10
24% 24%
-90%
Net Profit -4.85 -4.85
24% 24%
-85%

In millions USD.

Don't miss a Thing! We will send you all news about Biomerica, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biomerica, Inc. Stock News

Neutral
GlobeNewsWire
10 days ago
IRVINE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), an innovator in diagnostic-guided therapy, today announced compelling real-world results demonstrating the effectiveness of its inFoods® IBS product, along with the launch of a proprietary real-time patient feedback system to enhance symptom tracking and improve patient outcomes.
Neutral
GlobeNewsWire
25 days ago
- Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company dedicated to the development of advanced diagnostic products, announ...
Neutral
GlobeNewsWire
about one month ago
IRVINE, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced today that its Fortel® Ulcer Test has been approved for sale by the United Arab Emirates (UAE) Ministry of Health and Prevention. This regulatory approval enables Biomerica to introduce its rapid point-of-care test for Helicobacter pylori (H. pylori) i...
More Biomerica, Inc. News

Company Profile

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.

Head office United States
CEO Zackary Irani
Employees 64
Founded 1971
Website biomerica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today